I initiate coverage on Haleon with a "hold" rating due to decent results and potential for ongoing growth, despite a slight revenue slip last year. Haleon's dividend grew 10% and is well-covered ...
Shares of HLN opened at $10.45 on Wednesday. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a 50-day moving average price of $9.66 and a two-hundred day moving ...
Hsbc Global Res lowered shares of Haleon (NYSE:HLN – Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Wednesday morning,Zacks.com reports.
Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands ...
In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...
KARACHI: Haleon Pakistan Limited, a consumer healthcare company, has renewed its collaboration with Smile Train, the world’s largest cleft organisation, to raise funds and support cleft care for ...
Haleon projects a gradual revenue and profit growth towards the second half of 2025, despite strong end-year sales in 2024. The company recorded 4-6 per cent projected organic revenue growth, with ...
Berenberg analyst Bethan Davies raised the firm’s price target on Haleon (HLN) to 457 GBp from 456 GBp and keeps a Buy rating on the shares. See what stocks are receiving Strong Buy ratings from ...
February 27, 2025 Sensodyne maker Haleon says 2025 revenue growth skewed to second half British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted ...
HSBC analyst Jeremy Fialko downgraded Haleon (HLN) to Hold from Buy with a 420 GBp price target See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze ...
Haleon reported FY24 revenue of £11.23B ($14.19B), down 0.6%, with 5% organic growth. Adjusted operating profit fell 6.5% to £2.50B. 2025 guidance projects 4-6% organic revenue growth, with ...